William G. Morice

9.9k total citations
90 papers, 3.4k citations indexed

About

William G. Morice is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, William G. Morice has authored 90 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 44 papers in Pathology and Forensic Medicine and 32 papers in Immunology. Recurrent topics in William G. Morice's work include Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (39 papers) and Multiple Myeloma Research and Treatments (20 papers). William G. Morice is often cited by papers focused on Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (39 papers) and Multiple Myeloma Research and Treatments (20 papers). William G. Morice collaborates with scholars based in United States, United Kingdom and Italy. William G. Morice's co-authors include Curtis A. Hanson, Paul J. Kurtin, S. Vincent Rajkumar, Angela Dispenzieri, Shaji Kumar, Ayalew Tefferi, Greg Wiederrecht, John J. Siekierka, G.J. Brunn and Robert T. Abraham and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

William G. Morice

85 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William G. Morice United States 34 1.3k 1.2k 1.1k 991 850 90 3.4k
C. Cameron Yin United States 37 1.7k 1.3× 1.7k 1.4× 841 0.7× 1.4k 1.5× 1.7k 2.0× 226 4.6k
Javier Briones Spain 35 1.3k 1.0× 957 0.8× 1.7k 1.5× 1.9k 1.9× 1.0k 1.2× 161 4.5k
Bruce Patterson Canada 32 1.3k 1.0× 641 0.5× 972 0.8× 1.2k 1.2× 919 1.1× 59 3.7k
Russell K. Brynes United States 35 913 0.7× 734 0.6× 755 0.7× 1.1k 1.1× 1.0k 1.2× 105 3.3k
Koji Izutsu Japan 35 2.0k 1.5× 730 0.6× 1.0k 0.9× 2.0k 2.1× 1.1k 1.3× 265 4.6k
Fiona E. Craig United States 29 1.4k 1.0× 736 0.6× 1.2k 1.1× 1.4k 1.4× 801 0.9× 104 4.0k
Naokuni Uike Japan 37 1.8k 1.3× 852 0.7× 2.5k 2.2× 1.8k 1.8× 772 0.9× 151 5.1k
Lubomir Sokol United States 37 2.0k 1.5× 1.4k 1.2× 1.4k 1.2× 1.8k 1.8× 1.3k 1.6× 269 5.3k
Alessandro Pulsoni Italy 30 2.1k 1.6× 1.2k 1.1× 524 0.5× 1.9k 2.0× 858 1.0× 143 4.5k
Françoise Valensi France 30 1.2k 0.9× 1.1k 0.9× 733 0.6× 876 0.9× 936 1.1× 86 3.5k

Countries citing papers authored by William G. Morice

Since Specialization
Citations

This map shows the geographic impact of William G. Morice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William G. Morice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William G. Morice more than expected).

Fields of papers citing papers by William G. Morice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William G. Morice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William G. Morice. The network helps show where William G. Morice may publish in the future.

Co-authorship network of co-authors of William G. Morice

This figure shows the co-authorship network connecting the top 25 collaborators of William G. Morice. A scholar is included among the top collaborators of William G. Morice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William G. Morice. William G. Morice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaufman, Harvey W., William A. Meyer, Nigel J. Clarke, et al.. (2023). Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology. Population Health Management. 26(1). 29–36. 4 indexed citations
2.
Seheult, Jansen N., Gregory E. Otteson, Dragan Jevremović, et al.. (2023). Establishing NK-Cell Receptor Restriction by Flow Cytometry and Detecting Potential NK-Cell Clones of Uncertain Significance. Modern Pathology. 36(8). 100255–100255. 5 indexed citations
3.
Zhao, Fang, Jennifer L. Oliveira, Yuan Ji, et al.. (2022). Isolated anemia in patients with large granular lymphocytic leukemia (LGLL). Blood Cancer Journal. 12(2). 30–30. 6 indexed citations
4.
Awasthi, Samir, Tyler Wagner, AJ Venkatakrishnan, et al.. (2021). Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients. Cell Death Discovery. 7(1). 55–55. 28 indexed citations
5.
Foucar, Kathryn, Eric D. Hsi, Sa A. Wang, et al.. (2020). Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study. International Journal of Laboratory Hematology. 42(4). 418–422. 15 indexed citations
6.
Sidiqi, M Hasib, Mohammed A. Aljama, Dragan Jevremović, et al.. (2018). Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation. Haematologica. 103(7). 1229–1234. 3 indexed citations
7.
Goyal, Tanu, Beenu Thakral, Sa A. Wang, et al.. (2017). T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas. American Journal of Clinical Pathology. 149(2). 164–171. 13 indexed citations
8.
Bianchi, Giada, Robert A. Kyle, Dirk R. Larson, et al.. (2012). High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma. Leukemia. 27(3). 680–685. 112 indexed citations
9.
Jouni, Hayan, et al.. (2012). A classic case of amyloid cardiomyopathy. BMJ Case Reports. 2012. bcr2012006937–bcr2012006937. 1 indexed citations
10.
Dronca, Roxana, Dragan Jevremović, Curtis A. Hanson, et al.. (2010). CD5‐positive chronic B‐cell lymphoproliferative disorders: Diagnosis and prognosis of a heterogeneous disease entity. Cytometry Part B Clinical Cytometry. 78B(S1). S35–41. 26 indexed citations
11.
Morice, William G., Dong Chen, Paul J. Kurtin, Curtis A. Hanson, & Ellen D. McPhail. (2009). Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia. Modern Pathology. 22(6). 807–816. 105 indexed citations
12.
Shanafelt, Tait D., Neil E. Kay, Tim G. Call, et al.. (2008). MBL or CLL: Which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5×109L−1 but a B-cell lymphocyte count <5×109L−1?. Leukemia Research. 32(9). 1458–1461. 31 indexed citations
13.
Feldman, Andrew L., Mark E. Law, Anne J. Novak, et al.. (2008). Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia. 22(6). 1139–1143. 107 indexed citations
14.
Morice, William G., et al.. (2007). Flow Cytometric Assessment of T-cell Chronic Lymphoproliferative Disorders. Clinics in Laboratory Medicine. 27(3). 513–532. 14 indexed citations
15.
Grogg, Karen L., William G. Morice, & William R. Macon. (2007). Spectrum of bone marrow findings in patients with angioimmunoblastic T‐cell lymphoma. British Journal of Haematology. 137(5). 416–422. 29 indexed citations
16.
Doǧan, Ahmet & William G. Morice. (2004). Bone marrow histopathology in peripheral T‐cell lymphomas. British Journal of Haematology. 127(2). 140–154. 40 indexed citations
17.
Morice, William G., et al.. (2003). Clinical features in T‐cell vs. natural killer‐cell variants of large granular lymphocyte leukemia. European Journal Of Haematology. 71(4). 263–265. 22 indexed citations
18.
Pardanani, Animesh, William G. Morice, James D. Hoyer, & Ayalew Tefferi. (2003). Chronic basophilic leukemia: a distinct clinico‐pathologic entity?. European Journal Of Haematology. 71(1). 18–22. 17 indexed citations
19.
Rao, Ravi D., William G. Morice, & Robert L. Phyliky. (2002). Hemophagocytosis in a Patient With Chronic Lymphocytic Leukemia and Histoplasmosis. Mayo Clinic Proceedings. 77(3). 287–290. 29 indexed citations
20.
Morice, William G., Paul J. Kurtin, & Jeffrey L. Myers. (2002). Expression of Cytolytic Lymphocyte-Associated Antigens in Pulmonary Lymphomatoid Granulomatosis. American Journal of Clinical Pathology. 118(3). 391–398. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Cameron Yin Breakdown of academic impact, for papers by Javier Briones Breakdown of academic impact, for papers by Bruce Patterson Breakdown of academic impact, for papers by Russell K. Brynes Breakdown of academic impact, for papers by Koji Izutsu Breakdown of academic impact, for papers by Fiona E. Craig Breakdown of academic impact, for papers by Naokuni Uike Breakdown of academic impact, for papers by Lubomir Sokol Breakdown of academic impact, for papers by Alessandro Pulsoni Breakdown of academic impact, for papers by Françoise Valensi
Rankless by CCL
2026